The difference between p53 mutation frequency in haematological and non-haematological malignancies: Possible explanations

G. Calin, Mircea Ivan, D. Stefanescu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

p53 gene mutations are the most frequent alterations in human cancers. In the published literature, a highly significant statistical difference between the prevalence of p53 mutations in haematological (H) and non-haematological (NH) malignancies can be found. However, no consistent reasons have been suggested to explain it. We propose two non-exclusive possibilities: (i) in H tumours p53 is altered with the same frequency as in NH tumours, but mechanisms other than mutations are involved and (ii) in H malignancies the prevalence of p53 mutations is much lower than in NH cancers because other genetic disturbances are involved. We hypothesized that retention of wild-type p53 in H cancers may be a consequence of: (a) the presence of telomerase activity in haematological cells and/or (b) the absence of hypoxia in the majority of H tumours.

Original languageEnglish (US)
Pages (from-to)326-328
Number of pages3
JournalMedical Hypotheses
Volume53
Issue number4
DOIs
StatePublished - Oct 1999
Externally publishedYes

Fingerprint

Mutation Rate
Neoplasms
Mutation
Telomerase
p53 Genes

ASJC Scopus subject areas

  • Developmental Biology
  • Medicine(all)
  • Drug Discovery

Cite this

The difference between p53 mutation frequency in haematological and non-haematological malignancies : Possible explanations. / Calin, G.; Ivan, Mircea; Stefanescu, D.

In: Medical Hypotheses, Vol. 53, No. 4, 10.1999, p. 326-328.

Research output: Contribution to journalArticle

@article{f41025b269da4b3697c628ee40f8b5ec,
title = "The difference between p53 mutation frequency in haematological and non-haematological malignancies: Possible explanations",
abstract = "p53 gene mutations are the most frequent alterations in human cancers. In the published literature, a highly significant statistical difference between the prevalence of p53 mutations in haematological (H) and non-haematological (NH) malignancies can be found. However, no consistent reasons have been suggested to explain it. We propose two non-exclusive possibilities: (i) in H tumours p53 is altered with the same frequency as in NH tumours, but mechanisms other than mutations are involved and (ii) in H malignancies the prevalence of p53 mutations is much lower than in NH cancers because other genetic disturbances are involved. We hypothesized that retention of wild-type p53 in H cancers may be a consequence of: (a) the presence of telomerase activity in haematological cells and/or (b) the absence of hypoxia in the majority of H tumours.",
author = "G. Calin and Mircea Ivan and D. Stefanescu",
year = "1999",
month = "10",
doi = "10.1054/mehy.1999.0764",
language = "English (US)",
volume = "53",
pages = "326--328",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - The difference between p53 mutation frequency in haematological and non-haematological malignancies

T2 - Possible explanations

AU - Calin, G.

AU - Ivan, Mircea

AU - Stefanescu, D.

PY - 1999/10

Y1 - 1999/10

N2 - p53 gene mutations are the most frequent alterations in human cancers. In the published literature, a highly significant statistical difference between the prevalence of p53 mutations in haematological (H) and non-haematological (NH) malignancies can be found. However, no consistent reasons have been suggested to explain it. We propose two non-exclusive possibilities: (i) in H tumours p53 is altered with the same frequency as in NH tumours, but mechanisms other than mutations are involved and (ii) in H malignancies the prevalence of p53 mutations is much lower than in NH cancers because other genetic disturbances are involved. We hypothesized that retention of wild-type p53 in H cancers may be a consequence of: (a) the presence of telomerase activity in haematological cells and/or (b) the absence of hypoxia in the majority of H tumours.

AB - p53 gene mutations are the most frequent alterations in human cancers. In the published literature, a highly significant statistical difference between the prevalence of p53 mutations in haematological (H) and non-haematological (NH) malignancies can be found. However, no consistent reasons have been suggested to explain it. We propose two non-exclusive possibilities: (i) in H tumours p53 is altered with the same frequency as in NH tumours, but mechanisms other than mutations are involved and (ii) in H malignancies the prevalence of p53 mutations is much lower than in NH cancers because other genetic disturbances are involved. We hypothesized that retention of wild-type p53 in H cancers may be a consequence of: (a) the presence of telomerase activity in haematological cells and/or (b) the absence of hypoxia in the majority of H tumours.

UR - http://www.scopus.com/inward/record.url?scp=0032711734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032711734&partnerID=8YFLogxK

U2 - 10.1054/mehy.1999.0764

DO - 10.1054/mehy.1999.0764

M3 - Article

C2 - 10608267

AN - SCOPUS:0032711734

VL - 53

SP - 326

EP - 328

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 4

ER -